Literature DB >> 12830050

The sequence of vessel interruption during lobectomy for non-small cell lung cancer: is it indeed important?

Yael Refaely1, Siegal Sadetzki, Angela Chetrit, David A Simansky, Michael Paley, Baruch Modan, Alon Yellin.   

Abstract

OBJECTIVE: During pulmonary resections for non-small cell lung cancer, the pulmonary vein is traditionally interrupted first to prevent seeding of malignant cells and consequently decrease metastatic implantation. This hypothesis was never confirmed scientifically. The aim of the present study was to determine whether the sequence of vessel interruption during lobectomy (lobar vein or lobar artery first) affects disease recurrence.
METHODS: A historical prospective study was performed of 279 consecutive patients with complete follow-up, who survived lobectomy for non-small cell lung cancer during 1992 to 1998, in a single center. Pre-, intra-, and postoperative variables were collected from the medical records; recurrence and vital status were obtained from follow-up files, central population registry, and personal confirmation, updated to December 2000. Comparison of recurrence rates by sequence of ligation and other independent variables was assessed by univariate and multivariate logistic regression analyses.
RESULTS: A total of 133 patients (48%) had vein interruption before the artery (V-first) and 146 (52%) had artery interruption first (A-first). The distribution of demographic, clinical, and other characteristics was similar between the 2 groups, except for the operated side and performing surgeons. The morbidity, blood requirement, and length of stay were equal for both groups. The total recurrence rate (A-first, 53%; V-first, 51%) was similar. Multivariate analysis (controlling for the effect of the performing surgeon) revealed elevated risk for recurrence among patients with high disease stage (odds ratio = 2.54), male gender (odds ratio = 1.59), intraoperative lung manipulation (odds ratio = 2.72), and blood transfusion (odds ratio = 1.49). Sequence of vessel interruption was not found as a risk factor for recurrence (odds ratio = 1.29; 95% 0.73 to 2.29, P =.4).
CONCLUSIONS: Our results did not show that sequence of vessel interruption during lobectomy plays a role in tumor recurrence. A prospective study with randomization in selection of method as well as surgeons for each patient is needed to confirm these results.

Entities:  

Mesh:

Year:  2003        PMID: 12830050     DOI: 10.1016/s0022-5223(03)00022-9

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

1.  Detection of circulating tumor cells in pulmonary venous blood for resectable non-small cell lung cancer.

Authors:  Chao Lv; Bingtian Zhao; Limin Wang; Panpan Zhang; Yuanyuan Ma; Yuzhao Wang; Nan Wu; Ying Wu; Yue Yang
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

2.  Technical aspects of video-assisted and robotic-assisted thoracoscopic segmentectomy.

Authors:  Jon A Lutz; Gregor J Kocher
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Advantages and disadvantages of single incision VATS in major anatomical resection for lung cancer.

Authors:  Semih Halezeroğlu
Journal:  J Vis Surg       Date:  2017-08-30

4.  Effects of vessel interruption sequence during thoracoscopic lobectomy for non-small cell lung cancer.

Authors:  Ryota Sumitomo; Takamasa Fukui; Satoshi Marumo; Yosuke Otake; Cheng-Long Huang
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-25

5.  Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study.

Authors:  Noriyuki Matsutani; Noriyoshi Sawabata; Masafumi Yamaguchi; Tetsukan Woo; Yujin Kudo; Akikazu Kawase; Satoshi Shiono; Hisae Iinuma; Shigeki Morita; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  Vein-first Lobectomy for Lung Cancer Assessed According to the Status of Clustered Circulating Tumour Cells.

Authors:  Noriyoshi Sawabata; Shigeru Nakane; Daiki Yoshikawa; Takashi Watanabe; Takeshi Kawaguchi; Noriko Ouji-Sageshima; Keiji Kushibe; Toshihiro Ito
Journal:  Cancer Diagn Progn       Date:  2021-11-03

7.  Curative Effects of Different Sequences of Vessel Interruption During the Completely Thoracoscopic Lobectomy on Early Stage Non-Small Cell Lung Cancer.

Authors:  Fengwei Li; Guanchao Jiang; Yingtai Chen; Jun Wang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-08-18       Impact factor: 1.520

8.  Wedge Resection of Tumor Before Lobectomy for Lung Cancer Could Be a No-touch Isolation Technique.

Authors:  Motoaki Yasukawa; Noriyoshi Sawabata; Takeshi Kawaguchi; Shigeki Taniguchi
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

9.  Association between different sequences of vessel ligation during video-assisted thoracoscopic lobectomy and survival in patients with non-small cell lung cancer.

Authors:  Huang-He He; Jia-Xi He; Zhe-Xue Hao; Wei Wang; Jian-Xing He
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

10.  Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Authors:  Masaki Hashimoto; Fumihiro Tanaka; Kazue Yoneda; Teruhisa Takuwa; Seiji Matsumoto; Yoshitomo Okumura; Nobuyuki Kondo; Tohru Tsujimura; Takashi Nakano; Seiki Hasegawa
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.